SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology, and practical application of nuclear medicine. The European Association of Nuclear Medicine (EANM) is a professional non-
Authors
- Elçin Zan (ORCID: https://orcid.org/0000-0003-0941-1466)
- Uwe Haberkorn
- Jérémie Calais (ORCID: https://orcid.org/0000-0002-8839-4379)
- Ken Herrmann
- Daniela E. Oprea‐Lager (ORCID: https://orcid.org/0000-0001-9447-2305)
- Christophe M. Deroose (ORCID: https://orcid.org/0000-0002-6080-1577)
- Jonathan McConathy (ORCID: https://orcid.org/0000-0003-4681-2322)
- Mark Konijnenberg (ORCID: https://orcid.org/0000-0001-5895-8500)
- Thomas A. Hope (ORCID: https://orcid.org/0000-0002-2228-5823)
- Ajit H. Goenka (ORCID: https://orcid.org/0000-0002-7804-2695)
- Laura Trimnal
Institutions
- San Francisco VA Medical Center (US)
- Cleveland Clinic (US)
- Mayo Clinic (US)
- Radboud University Nijmegen (NL)
- University of California, Los Angeles (US)
- German Cancer Research Center (DE)
- University of California, San Francisco (US)
- Heidelberg University (DE)
- Erasmus MC (NL)
- University Hospital Heidelberg (DE)
- Radboud University Medical Center (NL)
- University of California System (US)
- University of Alabama at Birmingham (US)
- Molecular Theranostics (United States) (US)
- UCSF Helen Diller Family Comprehensive Cancer Center (US)
- University of Duisburg-Essen (DE)
- Erasmus University Rotterdam (NL)
- KU Leuven (BE)
Publication Details
- Journal
- Journal of Nuclear Medicine
- Published
- 2024-11-21
- DOI
- https://doi.org/10.2967/jnumed.124.269002
- Citations
- 38
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 10.74
Funders
- Society of Nuclear Medicine and Molecular Imaging